CDC VAERS Data Myocarditis Pericarditis

 




Comments

Post a Comment

Popular posts from this blog

What are the odds that the company using an adjuvant that could [theoretically] induce #lupus has also just received FDA approval for a breakthrough lupus treatment?

Image
" I will just repeat something I've said before. Bookmark this tweet. Hydroxychloroquine will be required long term for people that signed up to investigational RNA therapy. The very same people that denigrated it." Did we all overlook the possible implications of this? @mentions The patent for this "bio-adjuvant" was registered in 2017. Here it is. Any mRNA candidate using this component therefore did not exist before 2017 and could not have been tested in the clinical arena before then. patentscope.wipo.int/search/en/deta… What are the odds that the company using an adjuvant that could [theoretically] induce  #lupus  has also just received FDA approval for a breakthrough lupus treatment? I'm so thankful that these companies can find the solutions to all these problems! According to the inventor Ugur Sahin, the first trials of the RNA vaccine candidates in humans was published in 2017 of 13 patients. The paper doesn't have a comprehensive methods sec...
Read more

Salk researchers and collaborators show how the protein damages cells, confirming COVID-19 as a primarily vascular disease

From Salk.Edu  https://www.salk.edu/news-release/the-novel-coronavirus-spike-protein-plays-additional-key-role-in-illness/ The novel coronavirus’ spike protein plays additional key role in illness Salk researchers and collaborators show how the protein damages cells, confirming COVID-19 as a primarily vascular disease LA JOLLA—Scientists have known for a while that SARS-CoV-2’s distinctive “spike” proteins help the virus infect its host by latching on to healthy cells. Now, a major new study shows that the virus spike proteins (which behave very differently than those safely encoded by vaccines) also play a key role in the disease itself. The paper, published on April 30, 2021, in Circulation Research, also shows conclusively that COVID-19 is a vascular disease, demonstrating exactly how the SARS-CoV-2 virus damages and attacks the vascular system on a cellular level. The findings help explain COVID-19’s wide variety of seemingly unconnected complications, and could open the door f...
Read more